Foundation for Innovative New Diagnostics

FIND’s key achievements in 2022 reflect the impact of the COVID-19 pandemic on our portfolio: alongside steady but at times delayed progress on our 40 product development projects, we led major advances in regional diagnostics manufacturing, evaluated more than 50 COVID-19 tests,and executed new partnerships that reflect an intensified awareness of the critical role played bydiagnostics in pandemic preparedness, disease surveillance, and primary care. Five key areas of focus in 2022 have included: -Regional diagnostics manufacturing/technology transfer. -Gonorrhoea RDT. -Essential primary care diagnostics in Indonesia -GAVI partnership on diagnostic tests for surveillance of vaccine-preventable diseases -HAT elimination